Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Proportional increase attributable to selected modifiable determinants of intermittent preventive treatment for malaria in pregnancy delivery

From: Factors affecting providers’ delivery of intermittent preventive treatment for malaria in pregnancy: a five-country analysis of national service provision assessment surveys

Barriers/Drivers Current prevalence* Proportional increase in IPTp (95% UI)
Removing user-fees for ANC medicines 12.2% 3.1% (1.4-6.5%)
Providing IPTp guidelines to all facilities 50.1% 5.5% (1.9-15.1%)
Integrating IPTp in routine ANC services 96.0% 3.2% (1.8-5.2%)
Preventing stock-outs of SP 10.7% 6.8% (4.1-10.4%)
Annual IPTp-training for providers 30.2% 13.9% (7.5-24.8%)
Joint effect   30.6% (20.7-44.2%)
  1. UI = uncertainty intervals; SP = sulphadoxine-pyrimethamine; IPTp = intermittent preventive treatment for malaria in pregnancy; ANC = antenatal care.
  2. *Prevalence estimates take into account the appropriate survey weights that were multiplied by the facility's number of ANC visits per month to represent the distribution of consultations for which the barrier/driver was present.